Patenting Nature: What Ruling in Myriad Case Means for Biotechnology and DNA Diagnostics

Thumbnail Image
View / Download280.6 KB

Date

2011-08-11

Authors

Cook-Deegan, Robert Mullan

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

389
views
282
downloads

Abstract

Type

Other

Department

Description

Editorial in 'The Cancer Letter', written by Professor Robert Cook-Deegan. This article was included in background materials provided at the September, 2011 Congressional briefing.

Provenance

Subjects

Genetics, Myriad Genetics, ACLU, BRCA, Breast Cancer, Amicus Brief, Gene Patents, Law, Health Policy, Medicine, Women’s Health

Citation

Permalink

https://hdl.handle.net/10161/7683

Citation

Cook-Deegan, Robert Mullan (2011). Patenting Nature: What Ruling in Myriad Case Means for Biotechnology and DNA Diagnostics. Retrieved from https://hdl.handle.net/10161/7683.

Collections

Materials from the Center for Public Genomics Congressional Briefing on the BRCA Patent Lawsuit on September 15, 2011
Full item page